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Factors associated with the effectiveness
and reach of NHS stop smoking services
for pregnant women in England
L. R. Vaz1*, T. Coleman1, S. J. Fahy1, S. Cooper1, L. Bauld2, L. Szatkowski1,3 and J. Leonardi-Bee1,3
Abstract
Background: The UK National Health Service provides Stop Smoking Services for pregnant women (SSSP) but there
is a lack of evidence concerning how these are best organised. This study investigates influences on services’ effectiveness
and also on their propensity to engage pregnant smokers with support in stopping smoking.
Methods: Survey data collected from 121/141 (86%) of SSSP were augmented with data from Hospital Episode Statistics
and the 2011 UK National Census. ‘Reach’ or propensity to engage smokers with support was defined as the percentage
of pregnant smokers setting a quit date with SSSP support, and ‘Effectiveness’ as the percentage of women who set a
quit date who also reported abstinence at four weeks later. A bivariate (i.e. two outcome variable) response Markov Chain
Monte Carlo model was used to identify service-level factors associated with the Reach and Effectiveness of SSSP.
Results: Beta coefficients represent a percentage change in Reach and Effectiveness by the covariate. Providing the
majority of one-to-one contacts in a clinic rather than at home increased both Reach (%) (β: 6.97, 95% CI:
3.34, 10.60) and Effectiveness (%) (β: 7.37, 95% CI: 3.03, 11.70). Reach of SSSP was also increased when the
population served was more deprived (β for increase in Reach with a one unit increase in IMD score: 0.55,
95% CI: 0.25, 0.85), had a lower proportion of people with dependent children (β: -2.52, 95% CI: -3.82, −1.22),
and a lower proportion of people in managerial or professional occupations (β: -0.31, 95% CI: -0.59, −0.03).
The Effectiveness of SSSP was decreased in those areas that had a greater percentage of people >16 years
with no educational qualifications (β: -0.51, 95% CI: -0.95, −0.07).
Conclusions: To engage pregnant smokers and to encourage them to quit, it may be more efficient for SSSP
support to be focussed around clinics, rather than women’s homes. Reach of SSSP is inversely associated with
disadvantage and efforts should be made to contact these women as they are less likely to achieve abstinence in the
short and longer term.
Keywords: Smoking, Pregnancy, Stop smoking services
Background
Smoking during pregnancy is a public health problem of
international concern. In high-income countries large
numbers of women smoke when pregnant; prevalence is
reported as 30–35% in Spain [1] and in 2010, 26% of UK
women smoked in pregnancy, with 12% smoking con-
tinuously throughout gestation. [2] Similar estimates
have been reported in Canada and Japan (10%), [3, 4]
with a slightly higher prevalence in the USA (14%). [5]
There are lower rates in low and middle income coun-
tries but these are increasing such that the World Health
Organisation (WHO) describes a developing epidemic of
smoking in pregnancy in these jurisdictions. [6] Concep-
tion is a life event which strongly motivates smokers
towards cessation, with around 50% of smokers trying to
stop during pregnancy. [7] Sustained smoking abstinence
which begins in pregnancy not only benefits smokers; it
very likely also improves their children’s health. Smoking
during pregnancy is associated with increased risk of low
birthweight and preterm birth. [8] However, while children
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of non-smokers are less likely to become smokers; [9] the
impact of maternal smoking on future child smoking ap-
pears to be exerted after childbirth, rather than as a result
of ‘in utero’ effects [10].
Counselling [11] and self-help [12] interventions are
effective for helping pregnant smokers to stop and the
former also improve adverse birth outcomes. [11] How-
ever, few countries systematically offer smoking cessa-
tion support to pregnant women, despite this being
consistent with Article 14 of the Framework Convention
on Tobacco Control, [13] the international public health
treaty which has been adopted by WHO. The UK is one
country which offers no-cost smoking cessation support
to all pregnant women; such support is provided by local
stop smoking services (SSS) which are available nation-
ally. Individuals are able to access one-to-one support,
behavioural support, pharmacotherapy and incentives
depending upon availability at the local SSS. SSS for all
smokers were first introduced in 1999, and from 2000,
tailored SSS which serve pregnant smokers were funded.
Although stop smoking services for pregnancy (SSSP)
are now mature components of the UK National Health
Service (NHS), there is only limited evidence to guide
their provision. In comparison, UK SSS for non-
pregnant smokers have been evaluated such that, short
[14] and longer term outcomes [15] are known and out-
come variations have been investigated. [16] In the non-
pregnant population, group support helped a greater
number of smokers to quit at four weeks, and SSS in
more deprived areas reached more people, but SSS that
operated in these more disadvantaged areas had lower
cessation rates than those in more affluent areas [16].
However, as pregnancy is a unique life event, with po-
tentially differing motivations for quitting and physio-
logical strength of addiction, one cannot assume that the
evidence for services aimed at non-pregnant smokers
applies to SSSP. Pregnant smokers are often more disad-
vantaged, and those who are disadvantaged are often less
likely to receive necessary care. [17] Consequently, we
used a detailed survey to describe key variations in
English SSSP. [18] Here survey information is com-
bined with census and routinely-available data on
smoking in pregnancy and on SSSP performance to
determine the SSSP features which are associated
with attracting pregnant smokers into treatment and
with the outcomes of support.
Methods
Data sources
Data for this study were derived from a survey of SSSP,
[18] routinely reported stop smoking service perform-
ance data [19] and Hospital Episode Statistics (HES).
[20] In addition, data from the 2011 UK National
Census, aggregated at the SSSP level, was used to
determine, within each SSSP area, the proportions of
people who were not of ‘white’ or ‘mixed’ ethnicity; who
were ≥16 years old with no qualifications; who had chil-
dren; were working in managerial or professional occu-
pations; and were <18 years of age. [21] The average
index of multiple deprivation (IMD) score for the loca-
tion the SSSP was situated in was taken from statistics
compiled by the UK Government. [22] The IMD is a
composite measure that combines indicators of
deprivation across seven different domains: income,
employment, health and disability, education, crime,
barriers to housing and services, and living environ-
ment. A higher score is associated with increased
levels of deprivation.
The survey of SSSP was designed and implemented
using Qualtrics software (Qualtrics Labs Inc., Provo,
UT) and asked about the period between April 2010 and
March 2011. The online survey was originally piloted in
14 services and pilot responses were analysed along with
the responses from other SSSP. An online survey link
was sent to managers of all 141 SSSP services in England
via email and non-responders were contacted via email
after three to four months. If after this, no response was
received, contact was made via telephone and a hard
copy, electronic copy or a copy via telephone was com-
pleted. Services that completed this (N = 121, 86%)
tended to support more pregnant women and provide
more effective cessation support than non-respondent
services. [18] The original survey found that there were
no systematic differences between responding and non-
responding SSSP to the survey with respect to area level
IMD or self-reported quit rates [18]. However, respond-
ent services were more likely to have greater number of
women set quit dates and to have quit by four weeks.
[18] Carbon monoxide validation was also more
complete in respondent SSSP and there was borderline
evidence (p = 0.05) that respondent SSSP were more
likely to have smoking status at time of delivery. [18]
A full list of independent variables included in the ana-
lyses and the sources from which these were derived is
detailed in Table 1; this also includes the rationale for
each variable’s inclusion and, where available, references
to justify why these were considered to have the poten-
tial to influence outcomes. Where references are not
used alongside justifications in Table 1, variables were
included on the basis of the authors’ opinion.
Derivation of dependant variables, ‘reach’ and ‘effectiveness’
Reach
A measure called ‘Reach’ was developed to provide an
estimate of SSSP success in engaging pregnant smokers
to access cessation support. This was defined as the per-
centage of all pregnant smokers residing within an area
served by a SSSP who, with SSSP support, set a date for
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Table 1 Variables considered for inclusion in the model
Independent variable Description, source & justification Dependent variable tested
against
The mean index of multiple deprivation (IMD) Continuous variable. SSSP level IMD was used. IMD score
ranged from 9 to 43, with higher score indicating greater
deprivation. Taken from UK Data Service Census Support.
[22] Measures of deprivation were inversely associated with
pregnant smokers’ cessation in a recent large RCT. [34] SSS
for non-pregnant smokers have successfully attracted
smokers from lower socio economic groups. [31]
Reach, [31] Effectiveness [34]
Survey data
Whether or not mandatory midwifery training in
local hospitals included smoking cessation
Binary variable. SSSP in which midwifes received smoking
cessation training versus those who did not. It was
hypothesised that training could influence propensity for
midwives to refer women to SSSP and initial midwife
contacts may be more effective at promoting smoking
cessation.
Reach, Effectiveness
Whether or not identification of smokers used CO
monitoring and an opt-out referral pathway
Binary variable. SSSP in which the opt-out referral pathway
was used versus those that did not. This kind of referral
pathway has been shown to increase SSSP referrals
(and hence Reach) [35] and has been associated with
better service outcomes in an observational study. [36]
Reach, [35] Effectiveness [36]
Whether or not the Commissioning for Quality and
Innovation (CQUIN) framework [37] was in place for
referrals to the SSSP
Binary variable. SSSP in which either the CQUIN was in
place for recording smoking status, referrals, providing
brief advice or any other, versus not being so. We
hypothesised that having such a local policy in place
which encouraged identification of smokers could result
in greater Reach.
Reach
Whether the SSSP used social networking sites to
engage women
Binary variable. SSSP in which specialist cessation service
offered was advertised using any social networks. We
hypothesised that services which pro-actively attempted
to engage with women in this way may have greater Reach.
Reach
Whether SSSP staff initially contacted referred
pregnant smokers by phone
Binary variable. SSSP that initially contacted women via
phone as opposed to letter, SMS, email, face-to-face contact,
home visit or if pregnant women contacted the service.
We hypothesised that the manner of initial contact could
have consequences for Reach.
Reach
Whether the majority of one-to-one support offered
by the SSSP was at home or in the clinic
Binary variable. SSSP that offered more behavioural support
at home as opposed that offered in the clinic. We
hypothesised that offering support at home might influence
Reach; there is evidence that for non-pregnant smokers,
location of support provision can influence the Effectiveness
of support delivered. [38]
Reach, Effectiveness [38]
Whether the SSSP centre offered couple or family
support
Binary variable. SSSP that provided behavioural support in
the form of couple or family support versus those that
did not. We hypothesised that offering partner support
might increase the likelihood of women attending SSSP
(Reach); partner support is a key variable influencing
pregnant women’s success in cessation attempts. [39]
Reach, Effectiveness [39]
Whether there were any financial incentives
offered by the SSSP
Binary variable. SSSP that provided an incentive scheme for
pregnant women versus those that did not. We hypothesised
that the availability of incentives might affect women’s
propensity to engage with services; a recent trial has shown
these to be effective in the SSSP context. [40]
Reach, Effectiveness [40]
Whether self-referral patients accounted for one
of the top three referral methods to the SSSP
Binary variable. SSSP in which self-referral was at least the
third most popular referral method, versus those in which
it was not. We hypothesised that flexibility in accepting
referrals might affect Reach.
Reach
Whether the SSSP offered ‘dual therapy’ nicotine
replacement therapy (NRT) (i.e. longer and shorter
acting preparations used together)
Binary variable. SSSP that offered dual therapy NRT with or
without behavioural support versus SSSP that did not.
Although there is no evidence that standard dose NRT
works we hypothesised that higher doses from use of
‘dual therapy’ might be effective.
Effectiveness
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quitting smoking: data on whether or not clients set quit
dates with SSSP support were routinely collected by
SSSPs. The numerator for this measure was taken from
SSSP statistics routinely reported quarterly to the UK
Department of Health (DH); all stop smoking services
(SSS) tell the DH the numbers of smokers who have set
‘quit dates’ with SSS support. [23] Data for the number
of pregnant smokers in areas served by SSSP are not
routinely available and so were derived using a synthetic
estimation procedure. [24] This involved building a
multilevel logistic regression model using data from the
2010 Infant Feeding Survey (IFS) to estimate the prob-
ability of a pregnant woman smoking at any point dur-
ing her pregnancy according to her age, IMD quintile,
and the ethnicity profile of the area in which she lived.
[24] To estimate the number of smokers in any one
SSSP area, with Bayesian 95% Credible Intervals, these
probabilities were applied to numbers of women with
these socio-demographic characteristics giving birth in
that area, derived from 2010/11 HES. Further details
about this synthetic estimation procedure, and discus-
sion of the validity of the estimates, have been published
elsewhere [24].
Effectiveness
Our Effectiveness measure was designed to reflect SSSP
success in helping smokers achieve abstinence in any
one quit attempt; this was defined as the percentage of
those pregnant smokers who set a quit date with SSSP
support who reported abstinence four weeks later. The
numerator and the denominator were taken from NHS
SSS statistics for April 2010 to March 2011, which are
routinely reported to DH [23].
Analysis strategy
Linear regressions and model building
Univariable linear regressions were carried out between
the outcomes of ‘Reach’ and ‘Effectiveness’ and the pre-
dictor variables (Table 1). Variables which showed sig-
nificant (p ≤ 0.1) associations in the univariable models
were initially included in a bivariate response model in
which both ‘Reach’ and ‘Effectiveness’ were modelled
jointly. In building a parsimonious model with as few
predictors as possible, variables found to be non-
significant in the bivariate response model were then
removed; this minimised the variance of the model. Fol-
lowing this, all remaining predictor variables were tested
individually, beginning with those most strongly associ-
ated with either Reach or Effectiveness, to investigate
whether they became significant if added to the bivariate
response model. A bivariate response model was used as
the error terms in the equations for Reach and Effective-
ness were hypothesised to be correlated, i.e. Reach and
Effectiveness are associated, and by using this kind of
model, we hoped to produce more precise estimates.
Missing values and imputation
Missing data for predictor variables listed in Table 1
were imputed by Multiple Imputation using Chained
Equations (MICE). An imputation model was constructed
Table 1 Variables considered for inclusion in the model (Continued)
Census data
In the absence of a strong evidence base, all of the following variables were considered to have the potential to affect either Effectiveness or Reach
The proportion of women in the area covered
by the SSSP not of white or mixed ethnicity
Continuous variable. National census data aggregated at
the SSSP level. [21] We hypothesised women who did
not identify as white or mixed ethnicity might be less
likely to smoke and may be less likely to seek help to
quit smoking.
Effectiveness, Reach
The proportion of people aged ≥16 years in the
area covered by the SSSP with no qualifications
Continuous variable. National census data aggregated at
the SSSP level. [21] We hypothesised that the level of
education is inversely associated with the odds of cessation,
and may also be associated with awareness of harms and
thus, making a quit attempt.
Effectiveness, Reach
The proportion of people in the area covered
by the SSSP with dependent children
Continuous variable. National census data aggregated at
the SSSP level. [21] We hypothesised that having dependent
children may decrease the odds of being able to attend
clinic visits.
Effectiveness, Reach
The proportion of people in the area covered
by the SSSP in managerial or professional
occupations
Continuous variable. National census data aggregated at
the SSSP level. [21] We hypothesised women who are in
managerial or professional occupations may have higher
levels of education, and be less likely to smoke. They may
view themselves as less likely to need help and not attend
SSSP.
Effectiveness, Reach
The proportion of people in the area covered
by the SSSP aged <18 years
Continuous variable. National census data aggregated at
the SSSP level. [21] We hypothesised being of younger
age may affect women’s likelihood of quitting smoking.
Effectiveness, Reach
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based on selected predictor variables and the two outcome
variables, Reach and Effectiveness. The imputation model
was based on 10 imputed datasets [25] and an indicator
variable was included for clustering at the SHA level.
IGLS model for deriving starting parameter estimates for
bivariate model
An Iterative Generalised Least Squares (IGLS) model
using maximum likelihood estimates was used as an ini-
tial estimation method to provide non-informative priors
for a model using Markov Chain Monte Carlo methods
(MCMC). The analysis strategy, previously outlined in
the ‘linear regressions and model building’ section above,
was used to create the IGLS model. At the time of the
survey, SSSPs were commissioned by local Primary Care
Trusts (PCTs) which were clustered within larger Stra-
tegic Health Authorities (SHA); the public health team
within each SHA advised PCTs on the delivery of SSSP
and thus one could expect some similarities between
SSSPs delivered by PCTs in the same SHA. To account
for this clustering, a random effects model was used
with clustering at the level of the SHA.
MCMC estimating parameter estimates for bivariate model
A MCMC method using Gibbs Sampling method was
employed to provide model estimates. [26] MCMC
methods are used to efficiently sample from a compli-
cated distribution, such as a bivariate model for Reach
and Effectiveness of SSSP. A burn-in (i.e. period which
allows the Markov chains to converge) of 500 iterations
was used to achieve an equilibrium distribution, after
which these were discarded. A further 10,000 iterations
were then performed. [26] The trajectories of these sim-
ulations were checked for each variable to confirm that
they converged to a random scatter around a stable
mean. Stable simulations beyond the burn-in were used
to characterise the posterior distribution i.e. estimates
from the 10,000 iterations that were stable were used to
calculate the estimates for variables in the model. The
effective sample size (ESS) was maximised using hier-
archical centring which improved the efficiency of the
simulation and reduced the effect of autocorrelation (i.e.
an iterations’ result is dependent upon its place in the
sequence or related to other iterations). ESS represents
the independent draws the sample represents for each
parameter compared to the 10,000 iterations performed.
The larger the effective sample size, the better the pos-
terior distribution is sampled using MCMC, and less
likely iterations are to be autocorrelated. Further infor-
mation on the iterative MCMC procedure is published
elsewhere [26].
The fit of the variables in the MCMC estimation was
summarised using the Bayesian Deviance Information
Criterion (DIC). Bayesian DIC decreases with increasing
complexity of the model, so as the model increases in
size, variables added are less likely to be considered to
make a significant contribution to the model fit. A new
DIC was calculated after adding a variable to the model;
if the DIC decreased by more than two points, this indi-
cated that the model was a significantly better fit with
that variable included. [27] The MCMC estimation pro-
duced point estimates with 95% Credible Intervals.
Additionally, the Variance Partition Coefficient (VPC)
was also employed to measure the amount of clustering
by SHA. This measured the proportion of the variation
in Reach and Effectiveness that was explained by SSSPs
being located in different SHAs, and helped to indicate
whether changes in factors at the SHA level might influ-
ence the two outcomes.
Sensitivity analysis
To assess whether any bias had been introduced into the
model, a sensitivity analysis was conducted comparing
the model presented, which used multiple imputation
for missing data in predictor variables, with a compara-
tor model that used list-wise deletion for handling these
missing data. A second sensitivity analysis was also car-
ried out comparing the point estimates of the synthetic
estimates of the SSSP outcome variable, ‘Reach’, with the
associated 95% Credible Intervals. This was done to as-
sess whether differences in the parameter estimates of
Reach resulted in changes to the model produced.
All analyses were carried out using Stata 13.1 (College
Station, TX), MLwiN Version 2.30 (Centre for Multilevel
Modelling, University of Bristol) [28] and the ‘runmlwin’
Stata command [29].
Ethical approval and consent
This secondary analysis of data collected was conducted
in accordance within the ethical tenants of the declar-
ation of Helsinki (as revised in 1983). Ethics approval
was not required for data from the SSSP survey as it was
obtained as part of a service evaluation. Written consent
was received from the practice managers who provided
data for the SSSP survey. Routinely collected smoking
data did not require ethical approval as this was derived
from the publicly available UK national census. However,
as the Health & Social Care Information Centre
(HSCIC) makes HES and UK census data available for
research with the proviso of proper use, all data were
used in line with HSCIC policy of protecting the confi-
dentiality and privacy of individuals.
Availability of data and materials
Data used for this study were derived from a survey
of SSSP, [18] routinely reported stop smoking service
performance data [19] and Hospital Episode Statistics
(HES) [20]. Stop smoking service and HES data are
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available from their respective cited sources. Data
from the survey of SSSP is not available.
Results
121/141 (86%) of SSSP provided useable survey re-
sponses. The majority of SSSP provided services for a
single PCT with only 10 SSSP commissioned by more
than one PCT; consequently, we did not account for
clustering of SSSP within PCTs. The mean Reach of
SSSP (percentage of pregnant smokers in area served by
SSSP setting a quit date) was 17.2% (SD: 12.5%, n = 121)
and the mean Effectiveness (percentage of pregnant
smokers who set a quit date and reported cessation at
4 weeks) was 45.2% (SD: 11.4%, n = 121). Using data that
were complete we were able to impute values for those
predictor variables that had missing data. Outcomes
could not be calculated for two SSSP (Isle of Man,
Kensington & Chelsea) because data on the number of
quit dates was not available. Therefore, after multiple im-
putation, subsequent analysis was carried out in 139 SSSP.
The results of the univariable linear regressions dem-
onstrated that having the majority of support delivered
at a clinic was associated with increased Reach and
Effectiveness of SSSP (Tables 2 and 3). Both Reach and
Effectiveness of a SSSP were increased in areas where
there were more people over the age of 16 years with no
qualifications and in areas with a greater percentage of
people with dependent children. Thus, all variables that
were associated with Effectiveness were also associated
with Reach.
Reach was also increased in SSSPs that served a more
deprived (higher IMD score) population, offered finan-
cial incentives, had a specialist advisor who had received
some training in smoking cessation, and in areas where
a greater percentage of people were aged <18 years.
Reach of SSSP was inversely associated with the percent-
age of people of who did not identify as white or mixed
ethnicity and the percentage in managerial or profes-
sional occupations.
The parameter estimates for the predictor variables
modelled jointly for Reach and Effectiveness are pre-
sented in Table 4. The equation for Reach of SSSP ex-
plained 38.0% of the variation and the equation for
Effectiveness explained 15.0% of the variation. For each
unit increase in IMD, representing greater deprivation
within an area, there was a 0.55% increase in Reach of
SSSP indicating that pregnant women residing in areas
that were considered more deprived were more likely to
be reached by SSSP. Providing one-to-one support at a
clinic rather than in women’s homes was associated with
a 6.97% increase in the proportion of pregnant smokers
setting a quit date (i.e. Reach) and associated with a
7.37% increase in the proportion of women reporting
smoking cessation at four weeks post-quit date (i.e.
Effectiveness). For every 1% increase in the percentage
of people with dependent children or of people in man-
agerial or professional occupations residing in areas
served by SSSP, there was a 2.52% and 0.31% decrease in
SSSP Reach, respectively. Every 1% increase in the per-
centage of people aged 16 or older that had no qualifica-
tions residing in an SSSP catchment area was associated
with a 0.51% decrease in SSSP Effectiveness.
The VPC indicated that total proportion of the vari-
ance that was explained by differences at the SHA level
in the model for Reach and Effectiveness was 15.2% and
12.0% respectively; thus, the majority of variance, and
hence the majority of variation in SSSP performance,
was explained at the SSSP level rather than at SHA level.
The effective sample size was >1000 for each of the vari-
ables included in the model indicating an efficient
simulation.
Sensitivity analysis
The sensitivity analysis which investigated differences in
findings for the binary response model based on whether
the missing data was imputed or deleted in a list-wise
manner found no significant differences in results ob-
tained using these two strategies (results available upon
request). Additionally, findings from a sensitivity analysis
which compared the point estimates used for Reach with
those from the associated 95% Credible Intervals found
that the estimates for the predictor variables included in
the multivariable linear regression models did not
change substantially (results available upon request).
Discussion
This study has identified that the setting used by the
English smoking cessation services for providing cessa-
tion support in pregnancy (SSSPs) may affect important
service outcomes; when SSSPs primarily helped women
from clinic settings rather than through home visits,
they not only reached more smokers, but their support
was more effective too. Additionally we have shown how
local population characteristics might affect SSSP out-
comes. Being located in areas with greater material
deprivation, where fewer people have dependent chil-
dren and fewer people work in managerial occupations
was associated with SSSPs reaching and helping a higher
proportion of local pregnant smokers; English SSSP ser-
vices effectively target disadvantaged groups. However,
being in areas with more non-qualified 16 year olds was
inversely associated with SSSPs effectiveness; once using
the SSSPs, pregnant women from more disadvantaged
areas are less likely to quit.
This is the first study to investigate how the design of
nationally-provided services for smoking cessation in
pregnancy and the characteristics of women using these
might affect service outcomes. Information sources were
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robust; UK census data and small area statistics are of
very high quality; routinely-collected outcome data were
available for almost all SSSPs and the survey which pro-
vided data on service characteristics had a high response
rate. Together these factors suggest that findings are
likely to be relevant to SSSPs within the English NHS
and, potentially generalisable, to similar services serving
high-income countries where smoking in pregnancy is
concentred amongst materially deprived women. Findings
have face validity rather than being counter-intuitive. One
Table 2 Linear regression associations with “Reach”
N (%)/ mean 95% CI
Variable [SD]a βb Lower Upper p-value
Mean IMD score for SSSPc 23.27 [8.09] 0.38 0.17 0.59 0.004
Did employees mandatory midwifery training include smoking cessation?
No 48 (41.4) ref - - -
Yes 68 (58.6) 2.59 −1.10 6.28 0.247
Did identification of smokers use both CO monitoring and the opt-out referral pathway?
No 92 (79.3) ref - - -
Yes 24 (20.7) −0.51 −5.18 4.16 0.855
Was the Commissioning for Quality and Innovation (CQUIN) framework in place for referrals to the SSSP?
No 85 (78.0) ref - - -
Yes 24 (22.0) −2.14 −6.88 2.60 0.453
Did the SSSP used social networking site to engage women?
No 86 (81.1) ref - - -
Yes 20 (18.9) 2.94 −1.88 7.76 0.313
Did the SSSP initially contacted pregnant women by phone?
No 14 (12.1) ref - - -
Yes 102 (87.9) −1.82 −7.80 4.17 0.615
Was the majority of one-to-one support offered by the SSSP in the clinic?
No 57 (53.8) ref - - -
Yes 49 (46.2) 8.97 5.55 12.38 <0.001
Did the SSSP centre offer couple or family support?
No 60 (56.1) ref - - -
Yes 47 (43.9) −0.22 −4.27 3.84 0.929
Were financial incentives offered by the SSSP?
No 70 (64.8) ref - - -
Yes 38 (35.2) 4.38 0.46 8.30 0.067
Did the SSSP centre currently have a specialist advisor?
No 27 (22.7) ref - - -
Yes 92 (77.3) 10.77 6.86 14.68 <0.001
Did self-referral patients account for one of the top three referral methods to the SSSP?
No 48 (41.7) ref - - -
Yes 67 (58.3) 2.55 −1.21 6.31 0.263
Women who did not identify as white or mixed ethnicity women in
the area covered by SSSPc (%)
13.6 [14.9] −0.27 −0.38 −0.15 <0.001
People aged ≥ 16 years with no qualificationsc (%) 22.8 [4.9] 1.11 0.79 1.44 <0.001
People with dependent childrenc (%) 64.1 [1.9] −1.69 −2.60 −0.77 0.003
People in managerial or professional occupationsc (%) 36.1 [8.4] −0.61 −0.80 −0.41 <0.001
People aged < 18 yearsc (%) 18.4 [3.1] 0.65 0.07 1.23 0.064
aCounts and means prior to multiple imputation (N = 121)
bRegression coefficients based on 139 SSSPs, using results from imputed datasets
cRegression results for mean centred variables
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Table 3 Linear regression associations with “Effectiveness”
N (%)/ mean 95% CI
Variable (SD)a β Lower Upper p-value
Mean IMD score for SSSPb 23.27 [8.09] −0.09 −0.29 0.11 0.445
Did employees mandatory midwifery training include smoking cessation?
No 48 (41.4) ref - - -
Yes 68 (58.6) 1.25 −2.38 4.88 0.567
Did identification of smokers use both CO monitoring and the opt-out referral pathway?
No 92 (79.3) ref - - -
Yes 24 (20.7) −0.10 −4.34 4.14 0.969
Was the majority of one-to-one support offered by the SSSP in the clinic?
No 57 (53.8) ref - - -
Yes 49 (46.2) 6.62 3.12 10.12 0.002
Did the SSSP centre offer couple or family support?
No 60 (56.1) ref - - -
Yes 47 (43.9) −3.07 −6.65 0.50 0.157
Were financial incentives offered by the SSSP?
No 70 (64.8) ref - - -
Yes 38 (35.2) 0.42 −3.59 4.44 0.860
Did the SSSP centre currently have a specialist advisor?
No 27 (22.7) ref - - -
Yes 92 (77.3) 0.49 −3.33 4.32 0.831
Did the SSSP offer dual therapy NRT?
No 13 (12.0) ref - - -
Yes 95 (88.0) −1.78 −6.75 3.19 0.553
Women who did not identify as white or mixed ethnicity women in the area
covered by SSSPb (%)
13.6 [14.9] 0.08 −0.03 0.19 0.227
People aged ≥ 16 years with no qualificationsb (%) 22.8 [4.9] −0.51 −0.84 −0.19 0.009
People with dependent childrenb (%) 64.1 [1.9] 0.88 0.03 1.73 0.088
People in managerial or professional occupationsb (%) 36.1 [8.4] 0.13 −0.06 0.32 0.270
People aged < 18 yearsb (%) 18.4 [3.1] −0.48 −1.01 0.04 0.132
aCounts and means prior to multiple imputation
bRegression results for mean centred variables
Table 4 MCMC estimates
95% CI Difference in DIC
Variable β Lower Upper ESS
Reach
Mean IMD scorea,b 0.55 0.25 0.85 −11.59 7002
Majority of one-to-one support at clinic 6.97 3.34 10.60 −13.10 8798
Percentage of people with dependent childrena −2.52 −3.82 −1.22 −12.19 5259
Percentage of people in managerial or professional occupationsa −0.31 −0.59 −0.03 −3.10 4896
Effectiveness
Majority of one-to-one support at clinic 7.37 3.03 11.70 −13.99 9035
Percentage of people ≥ 16 years with no qualificationsa −0.51 −0.95 −0.07 −2.63 5281
amean centred variables
bhigher score = more deprived
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would expect area and service organisational characteris-
tics to influence SSSP ability to ‘Reach’ smokers more than
efficacy of SSSP interventions delivered. Also, as ex-
pected, these explained much more of the variance in
SSSPs’ ability to reach pregnant smokers than they
did in SSSP Effectiveness.
A limitation is that our analyses did not include
individual-level data on service users; instead, small area
census data have been used as a proxy. Systematic differ-
ences between women accessing SSSPs and the female
population of the areas in which they lived could affect
study findings. Although there is no reason to suppose
that systematic differences existed, findings are still
probably best used to inform us on key organisational is-
sues that affect service performance, rather than on what
influence clients’ characteristics might have. As analyses
were observational, we cannot claim a causal relation-
ship between factors identified as potentially-important
and the two outcomes. As much variance in these was
not explained by our models, it is possible that import-
ant influences on service outcomes were not captured
by data sources used in analyses. Consequently, there
may be other, as yet undescribed factors, which also con-
tribute to SSSP performance. Finally, findings may only
generalise to countries with a similar economic profile
to England’s; in jurisdictions in which the relationship
between deprivation and smoking in pregnancy is
weaker, there may be different influences on women’s
smoking behaviour in pregnancy and hence the ability of
health service interventions to influence this.
The finding that the provision of clinic-based support
was associated with SSSPs helping more pregnant
smokers to stop is important. In 2011, presumably to
encourage pregnant smokers to access SSSP, 73% of
English services offered resource-intensive home support
visits. [18] This rationale appears incorrect since this
study demonstrates clinic-based support was associated
with both increased rates of reach (setting a quit date)
and effectiveness (abstinence rates), which could be used
to argue for using clinics rather than women’s homes as
the primary location from which to offer support.
However, it is also possible that the apparently greater
effectiveness of clinic based support could be due to
women with higher motivation to quit making the effort
to attend clinic appointments. Amongst non-pregnant
smokers, greater motivation to stop is associated with
better attendance at SSS appointments [30] and motiv-
ation is a key determinant of success in smoking cessa-
tion attempts. Health services have little influence on
the underlying characteristics of the populations they
serve, but services do need to be configured to serve
populations appropriately and analysis outcomes are
reassuring on this point. As for SSS that treat non-
pregnant smokers [31], our analysis suggests that the
ability of English SSSP to engage with and support
smokers was increased in more deprived areas where a
higher proportion of pregnant smokers lived.
It is worth considering how NHS SSSP provision could
be altered in response to our findings that SSSP are rela-
tively successful at engaging with deprived pregnant
smokers but that deprivation is associated with poorer
cessation outcomes. Ideally, SSSP would ‘reach’ large
numbers of pregnant smokers and once such smokers
were engaged with support, cessation outcomes for de-
prived smokers would be at least similar and ideally bet-
ter than those for less deprived women. An audit of
Scottish SSSP presented observational data relating SSSP
throughput and outcomes with key characteristics; this
suggested that ‘opt out’ referral policies, in which all
smokers identified during routine antenatal care are re-
ferred for SSSP support, [32] might increase service
Reach. Subsequently, a before-after study run in one
NHS acute trust showed that introducing this kind of
referral pathway not only doubled the proportion of
women supported by SSSP (i.e. Reach) but it also dou-
bled their chance of short-term quitting (Effectiveness).
[33] A simple message for NHS cessation support pro-
viders is that ‘opt out’ referral pathways improve both
key service outcomes; further research is also needed to
determine how cessation outcomes for deprived smokers
who receive support can be further improved.
Conclusions
To our knowledge this is the first study to investigate
factors that are influential in national provision of smok-
ing cessation support in pregnancy. For rational use of
resources, those introducing similar support programmes
in other high-income countries should consider prioritis-
ing delivery of support from central locations and using
home support visits only in relatively exceptional circum-
stances. Further work is required to understand how char-
acteristics of individual pregnant women might affect
service outcomes, including the likelihood of these women
achieving abstinence from smoking. Furthermore, in order
to formally test the finding that clinic-based support is
more effective, SSSP practices may wish to stratify
routinely collected statistics by whether a home or
clinic service was provided.
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